Senhwa Biosciences (6492.TWO) Earnings Analysis
Senhwa Biosciences (6492.TWO) next reports earnings on 2026-08-06, consensus EPS -1.24 TWD. Last quarter (2026-03-11) it missed with EPS -0.91 TWD vs 4.21 TWD est (-121.6%). It has beaten estimates in 0/1 recent quarters (0%). Trailing P/E -13.84.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 6492.TWO next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -1.24 TWD |
| Revenue estimate | 0.00B |
6492.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-11 | -0.91 TWD | 4.21 TWD | -121.6% | Miss |
| 2025-08-11 | -0.63 TWD | n/a | n/a | n/a |
| 2025-05-12 | -0.69 TWD | n/a | n/a | n/a |
| 2025-03-12 | -0.90234 TWD | n/a | n/a | n/a |
| 2024-08-08 | -0.78102 TWD | n/a | n/a | n/a |
Beat rate: 0/1 (0%) over reported quarters with consensus data.
6492.TWO valuation and analyst view
| Trailing P/E | -13.84 |
|---|---|
| Trailing EPS | -3.03117 TWD |
| Price / book | 5.36 |
| Dividend yield | 0.00% |
| Market cap | 3.77B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Senhwa Biosciences (6492.TWO)'s next earnings date?
Senhwa Biosciences is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -1.24 TWD and revenue estimate of 0.00B.
Did 6492.TWO beat earnings last quarter?
In its 2026-03-11 report, 6492.TWO posted EPS of -0.91 TWD versus a 4.21 TWD estimate — a miss of 121.6%.
What is 6492.TWO's earnings track record?
Over the last 1 reported quarters with consensus data, 6492.TWO beat estimates 0 times (0%).
What is 6492.TWO's current P/E ratio and EPS?
6492.TWO trades at a trailing P/E of -13.84 on trailing EPS of -3.031166926484607 TWD.
What do analysts rate 6492.TWO?
6492.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.